Modena, A; Ciccarese, C; Iacovelli, R; Brunelli, M; Montironi, R; Fiorentino, Michelangelo; Tortora, G; Massari, F., Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?, «ONCOLOGY REVIEWS», 2016, 10, pp. 293 - 293 [articolo]Open Access
Barbaro, MARIA RAFFAELLA; Di Sabatino, Antonio; Cremon, Cesare; Giuffrida, Paolo; Fiorentino, Michelangelo; Altimari, Annalisa; Bellacosa, Lara; Stanghellini, Vincenzo; Barbara, Giovanni, Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism, «AMERICAN JOURNAL OF PHYSIOLOGY: GASTROINTESTINAL AND LIVER PHYSIOLOGY», 2016, 310, pp. 439 - 447 [articolo]
Thorgeirsson T; Jordahl KM; Flavin R; Epstein MM; Fiorentino M; Andersson SO; Andren O; Rider JR; Mosquera JM; Ingoldsby H; Fall K; Tryggvadottir L; Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToPCaP), Intracellular location of
BRCA2 protein expression and prostate cancer progression in the Swedish Watchful
Waiting Cohort, «CARCINOGENESIS», 2016, 37, pp. 262 - 268 [articolo]
Mengoli, Mc; Bertolini, F; Tiseo, M; Barbieri, F; Fiorentino, Michelangelo; Ardizzoni, Andrea; Rossi, G., MET DNA Alterations in NSCLC, «CLINICAL CANCER RESEARCH», 2016, 22, pp. 3697 - 3698 [articolo]
Graff, Re; Meisner, A; Ahearn, Tu; Fiorentino, Michelangelo; Loda, M; Giovannucci, El; Mucci, La; 2016 Apr 12, Pettersson A. Br J. C. a. n. c. e. r.; 114:939, 4. 4. doi: Epub 2016 Mar 1. 7. PubMed PubMed Central ., Pre-diagnostic circulating sex hormone levels and risk of
prostate cancer by ERG tumour protein expression., «BRITISH JOURNAL OF CANCER», 2016, 114, pp. 939 - 944 [articolo]
Giunchi, Francesca; Fiorentino, Michelangelo; Vagnoni, Valerio; Capizzi, Elisa; Bertolo, R; Porpiglia, F; Vatrano, S; Tamberi, S; Schiavina, Riccardo; Papotti, Michela; Bollito, E., Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients, «PATHOLOGY», 2016, 48, pp. 41 - 46 [articolo]
Giunchi, F; Panzacchi, R; Capizzi, E; Schiavina, R; Brunocilla, E; Martorana, G; D'Errico, A; Fiorentino, M, Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer, «CLINICAL GENITOURINARY CANCER», 2016, 14, pp. E307 - E312 [articolo]
Lu, D; Sinnott, Ja; Valdimarsdóttir, U; Fang, F; Gerke, T; Tyekucheva, S; Fiorentino, Michelangelo; Lambe, M; Sesso, Hd; Sweeney, Cj; Wilson, Km; Giovannucci, El; Loda, M; Mucci, La; Fall, K., Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer, «CLINICAL CANCER RESEARCH», 2016, 22, pp. 765 - 772 [articolo]
Saponara, Maristella; Gatto, Lidia; DI NUNNO, Vincenzo; Tabacchi, Elena; Fanti, Stefano; DI SCIOSCIO, Valerio; Nannini, Margherita; Gruppioni, Elisa; Altimari, Annalisa; Fiorentino, Michelangelo; Santini, Donatella; Ceccarelli, Claudio; Zompatori, Maurizio; Biasco, Guido; Pantaleo, MARIA ABBONDANZA, Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors, «ANTI-CANCER DRUGS», 2016, 27, pp. 353 - 363 [articolo]
Ciccarese C; Brunelli M; Montironi R; Fiorentino M; Iacovelli R; Heng D; Tortora G; Massari F., The prospect of precision therapy for renal cell carcinoma., «CANCER TREATMENT REVIEWS», 2016, 49, pp. 37 - 44 [articolo]
Ciccarese C.; Di Nunno V.; Montironi R.; Fiorentino M.; Brunelli M.; Tortora G.; Ardizzoni A.; Massari F., The role of precision medicine for the treatment of metastatic renal cell carcinoma, «EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT», 2016, 1, pp. 369 - 377 [articolo]
Farina, Eleonora; Monari, Fabio; Tallini, Giovanni; Repaci, Andrea; Mazzarotto, Renzo; Giunchi, Francesca; Panzacchi, Riccardo; Cammelli, Silvia; Padula, Gilbert D. A.; Deodato, Francesco; Pasquali, Renato; Fanti, Stefano; Fiorentino, Michelangelo; Morganti, Alessio G., Unusual Thyroid Carcinoma Metastases: a Case Series and Literature Review, «ENDOCRINE PATHOLOGY», 2016, 27, pp. 55 - 64 [articolo]
Yang, M; Zu, K; Mucci, La; Rider, Jr; Fiorentino, Michelangelo; Clinton, Sk; Loda, M; Stampfer, Mj; Giovannucci, E., Vascular morphology differentiates prostate cancer mortality risk among men with higher Gleason grade, «CANCER CAUSES & CONTROL», 2016, 27, pp. 1043 - 1047 [articolo]
Pultrone, C.; Schiavina, R.; Bianchi, L.; Zanoni, L.; Nanni, C.; Giunchi, F.; Bossert, I.; Fonti, C.; Borghesi, M.; Fiorentino, M.; Fanti, S.; Porreca, A.; Martorana, G.; Brunocilla, E., 18F-FACBC PET/CT FOR NODAL STAGING IN HIGH RISK PROSTATE CANCER: PRELIMINARY DIAGNOSTIC ACCURACY ANALYSIS, in: Atti 89° Congresso SIU 2016, 2016, pp. 335 - 335 (atti di: 89° Congresso SIU, Venezia, 15-18 Ottobre 2016) [atti di convegno-abstract]
R. Schiavina; E. Brunocilla; M. Borghesi; D. Romagnoli; F. Chessa; F. Giunchi; V. Vagnoni; D. Diazzi; H. Dababneh; C.V. Pultrone; F. Ceci; B. Corcioni; A. Porreca; R. Golfieri; M. Fiorentino; G. Martorana, Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up, in: ., 2015, pp. 821 - 821 (atti di: EAU Annual Congress, Madrid, 2015) [atti di convegno-abstract]
Schiavina Riccardo; Borghesi Marco; Brunocilla Eugenio; Romagnoli Daniele; Chessa Francesco; Giunchi Francesca; Vagnoni Valerio; Diazzi Davide; Dababneh Hussam; Pultrone Cristian Vincenzo; Ceci Francesco; Corcioni Beniamino; Porreca Angelo; Golfieri Rita; Fiorentino Michelangelo; Martorana Giuseppe, Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up, in: Acta PROSCA, 2015(atti di: Prosca, Rome, February 2015) [atti di convegno-poster]
